USA TODAY International Edition

Behind the viral craze for vitamin C

IV treatment claims lead to allegation­s of fraud

- Brent Schrotenbo­er

Wearing face masks and protective Tyvek suits with yellow boots, FBI investigat­ors recently raided a medical building in metro Detroit to gather evidence about an alleged fake treatment being sold for COVID- 19.

It looked like a drug bust. Authoritie­s sealed off the building’s entrance, carried away boxes and enlisted local police to secure the area.

But this wasn’t a rogue lab getting seized for illicit substances.

In this case, agents were investigat­ing a suspected scheme involving an essential nutrient found in orange juice, broccoli and strawberri­es: Vitamin C.

Otherwise known as ascorbic acid, this powerful antioxidan­t has become the subject of faith, controvers­y and even frequent government crackdowns during the pandemic. It’s also become more popular than ever, benefiting from religious- like claims and beliefs about its effectiveness against COVID- 19 despite not even having the power to cure the common cold.

“I am aware of no other nutrient that causes such emotion,” said Dr.

By early March, 21% in the U. S. thought taking vitamin C “probably” or “definitely” prevents coronaviru­s infection, and 26% were unsure.

National probabilit­y survey cited in a study of misinforma­tion on COVID- 19 by the Harvard Kennedy School

Daniel Monti, chair of Integrativ­e Medicine at Thomas Jefferson University in Philadelph­ia.

Consumers have shown that with their wallets, including some who mainline it into their veins or just load up on tablets. Vitamin C supplement sales soared to about $ 209 million during the first half of 2020, up 76% compared with the same period last year, according to Nielsen research.

In the federal case near Detroit, Dr. Charles Mok has been charged with health care fraud and is accused of using the pandemic as an opportunit­y to bill insurers, including Medicare, for high- dose vitamin C intravenou­s infusions that authoritie­s say were “fraudulent­ly represente­d as COVID- 19 treatments and preventati­ve measures.”

His case drew investigat­ors from the U. S. Department of Health and Human Services and the FBI, who wore protective gear during the raid in April to guard against exposure to COVID- 19. Mok’s next court date is set for September.

Since April, the Federal Trade Commission also has issued at least 37 warning letters to clinics and wellness centers across the nation, accusing them of overhyping similar high- dose IV infusions of vitamin C. The FTC regulates against deceptive business practices and accused the clinics of unlawfully marketing such therapies to prevent or treat COVID- 19, a disease without a proven cure or prevention.

Some claims were brazen. “Research shows that high dose Vitamin C is effective against COVID- 19,” said the website of the LaCava Center for Integrativ­e Medicine in St. Charles, Ill., according to the FTC’s warning in April. “GIVE US A CALL TODAY TO SCHEDULE YOUR VITAMIN C IV AT 50% OFF!”

The FTC told the firm and others to cease such claims because they lacked sufficient scientific evidence.

The businesses since have taken down their COVID claims, but many generally still offer such IV treatments to boost immunity and overall health despite being considered dubious by many experts.

Such treatments often sell for about $ 200 and are generally considered safe under proper medical oversight. But there are risks. They’re not scientifically proven, meaning customers might be spending their money on a service that may or may not work.

The history

So why all the fuss over a household vitamin that can be squeezed out of a grapefruit?

Because it’s a form of hope against the fear of the deadly coronaviru­s, medical experts say. And that hope has surged even though claims about its powers generally are unreliable, false or premature at best without more evidence from experiment­al clinical trials, according to experts in nutrition and medicine.

Vitamin C still has its champions. Take the case of movie and TV stuntman Greg Fitzpatric­k, the longtime double of actor Ben Stiller. Fitzpatric­k attributes his recovery from a prostate cancer diagnosis in 2016 to a change in diet and regular intake of high- dose vitamin C. He also continues to get 75 grams of IV therapy weekly because he said he believes it boosts his immune system and “keeps me healthy during COVID.”

“Can you prove it? I guess not,” Fitzpatric­k told USA TODAY. He said he believes in it “wholeheart­edly.”

Vitamin C “has not been studied with much rigor,” said Alexander Michels of the Linus Pauling Institute at Oregon State University, which studies the role of vitamins in human health. “The molecule – ascorbic acid – is not easy to work with and has properties that make it difficult to understand. Therefore, it has a long history of misunderst­anding in the scientific community and medical practice.”

Clinical trials involving COVID- 19 vitamin C treatments are pending and could take years before reaching conclusion­s. Monti’s team at Thomas Jefferson aims to see whether IV vitamin C can help prevent progressio­n of the disease and avoid the need to put patients on a ventilator.

“If I ever had to be treated for COVID, I would definitely push to be put on my own trial to get IV vitamin C – not because there is current proof it would do anything but because I believe there is a plausible mechanism that it might,” Monti said.

And then came a pandemic

Monti and other health care experts say most people generally get all the vitamin C they need by eating a good amount of fruits and vegetables, which helps boost their immune system and overall health.

But when the pandemic hit, people wanted to believe that consuming larger doses could defend the body against the novel coronaviru­s, echoing a similar theory that spread in the popular culture starting around 1970.

That’s when vitamin C evangelist Linus Pauling published his book “Vitamin C and the Common Cold,” which made the case that a bigger dose could build up a better defense, a notion now considered to be debatable at best and discredite­d at worst.

Fifty years later, the belief was again dispersed rapidly and globally.

❚ In January, misinforma­tion already was transmitti­ng on social media before the pandemic shut down the U. S. economy. In one example, a Facebook user advised people in the Philippine­s to “load up” on vitamin C to prevent COVID- 19, among other advice. That post was shared at least 15,000 times but ultimately was flagged for false informatio­n.

❚ By early March, 21% in the U. S. thought that taking vitamin C “probably” or “definitely” prevents infection and 26% were unsure, according to a national probabilit­y survey cited in a study of misinforma­tion on the disease by the Harvard Kennedy School.

On Instagram, actress Marla Maples, former wife of President Donald Trump, has been among those vouching for it.

“Now I’m getting a vitamin C drip ( IV),” she said in a March 13 post that showed her getting an infusion. “I’ve done this off and on for a few years, but right now I feel like it’s really more important because of the spread of the coronaviru­s and flus and other viruses we may not even know of that are in our world.”

Maples didn’t respond to a message seeking comment through her website.

❚ By late March, the Australian government decided to respond to an unspecified report that said intravenou­s high- dose vitamin C may be beneficial in the management of a COVID- 19 infection.

“We have investigat­ed this report and found there is no robust scientific evidence to support the usage of this vitamin in the management of COVID- 19,” said Australia’s Therapeuti­c Goods Administra­tion.

❚ In the U. S., health- related businesses started trying to cash in with IV therapies, citing reports of positive results from China in the treatment of COVID- 19. After the FTC cracked down, many cut the claims.

In the Detroit area case, Dr. Mok’s Allure Medical spa based in Shelby Township “submitted at least 98 claims to insurance companies, including Medicare, related to Vitamin- C infusion therapy services offered to patients as purported COVID- 19 treatment and preventati­ve care,” according to the federal criminal complaint against him. His attorney declined comment.

Such firms generally are for- profit and are not taking part in experiment­al clinical trials seeking to establish scientific evidence on vitamin C. In those clinical trials, intravenou­s vitamin C has shown promise in treatments for sepsis and some tumor types, Monti said.

By contrast, many wellness centers and naturopath­ic firms still offer unproven intravenou­s vitamin C therapies, saying they boost immunity and health with antioxidan­ts.

“Higher blood levels of vitamin C can be achieved with IV infusion than with oral intake, and that would be the argument for IV administra­tion,” said Dr. David Katz, a preventati­ve medicine specialist and founding director of Yale University’s Yale- Griffin Prevention Research Center. “I am aware of no actual evidence of benefit, so this is hope and wishful thinking on the part of the recipient, and opportunis­m and exploitati­on on the part of the provider.”

The manner in which these injectable vitamin C products are sold and distribute­d also is murky under the law.

Only one vitamin C injection product has been approved for use in the U. S. by the Food and Drug Administra­tion, which regulates drug safety and effectiveness. That product is Ascor by McGuff Pharmaceut­icals and is approved only for the short- term treatment of scurvy, a disease caused by vitamin C deficiency.

Yet the wellness firms that sell IV therapies are not treating scurvy and don’t necessaril­y require a prescripti­on, depending on the dosage. Several said they obtain the vitamin C from compoundin­g pharmacies, which don’t appear to be selling Ascor and might get the vitamin C from elsewhere, sometimes derived from corn.

So then how are these other vitamin C injection products compliant with the law?

“This is a very complicate­d question and has been at the heart of various changes and the evolution of compoundin­g pharmacy laws and regulation­s for many years,” said Nicholas Hoang of McGuff Pharmaceut­icals, the maker of Ascor.

The FDA didn’t answer a request for clarity. Pharmacies that were identified as providing these products to wellness firms didn’t immediatel­y return messages, nor did naturopath­ic doctors with expertise in IV therapies.

Compoundin­g pharmacies do have some legal leeway when tailoring drugs for individual­s, as do doctors who can make approved drugs available for offlabel uses. But how the vitamin C IV business jibes with the FDA isn’t clear, nor is much of the science surroundin­g vitamin C for consumers. In general, Monti said, vitamin C has provoked strong claims from famous scientists for decades, as well as strong counterarg­uments from others.

“If ( consumers) take it and see a positive effect, who can really discount their experience?” Michels of the Pauling Institute said in an e- mail. “On the other hand, the science is lagging far, far behind. Consumers, doctors, and scientists alike often think they know everything there is to know about vitamin C, but most of them have an incomplete picture. Even those who have dedicated their lives to studying this vitamin admit that they know very little.”

Newspapers in English

Newspapers from United States